Effects of Antitumor Drug Sorafenib on Chick Embryo Development. 2015

Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
Division of Histology and Embryology, Key Laboratory for Regenerative Medicine of the Ministry of Education, Medical College, Jinan University, Guangzhou, 510632, China.

Sorafenib has been used as an oral anti-cancer drug because of its ability to inhibit tumor growth. However, the pharmacological effect of sorafenib is still the lack of in vivo experimental evidence. Tumor and embryonic cells share some similar features, so we investigated the effects of sorafenib on the development of gastrulating chick embryos. We found that sorafenib exposure was markedly attributed to the number of embryonic cell in proliferation and apoptosis. We also detected sorafenib significantly interfered with epithelial-mesenchymal transition (EMT). Furthermore, sorafenib treatment impaired the production and migration of neural crest cells.

UI MeSH Term Description Entries
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D010671 Phenylurea Compounds Compounds that include the amino-N-phenylamide structure. Phenylcarbamides,Phenylurea Derivatives,Compounds, Phenylurea,Derivatives, Phenylurea
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D000077157 Sorafenib A niacinamide and phenylurea derivative that inhibits multiple intracellular and cell surface kinases thought to be involved in ANGIOGENESIS, including RAF KINASES and VEGF RECEPTORS. It is used in the treatment of advanced RENAL CELL CARCINOMA and HEPATOCELLULAR CARCINOMA, and for treatment of THYROID CARCINOMA refractory to radioactive iodine therapy. 4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate,BAY 43-9006,BAY 545-9085,BAY-545-9085,BAY-673472,Nexavar,Sorafenib N-Oxide,Sorafenib Tosylate,BAY 43 9006,BAY 439006,BAY 545 9085,BAY 5459085,BAY 673472,BAY5459085,Sorafenib N Oxide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D047108 Embryonic Development Morphological and physiological development of EMBRYOS. Embryo Development,Embryogenesis,Postimplantation Embryo Development,Preimplantation Embryo Development,Embryonic Programming,Post-implantation Embryo Development,Postnidation Embryo Development,Postnidation Embryo Development, Animal,Pre-implantation Embryo Development,Prenidation Embryo Development, Animal,Development, Embryo,Development, Embryonic,Development, Postnidation Embryo,Embryo Development, Post-implantation,Embryo Development, Postimplantation,Embryo Development, Postnidation,Embryo Development, Pre-implantation,Embryo Development, Preimplantation,Embryonic Developments,Embryonic Programmings,Post implantation Embryo Development,Pre implantation Embryo Development

Related Publications

Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
March 1989, British poultry science,
Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
April 1981, Journal of embryology and experimental morphology,
Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
December 1974, Experientia,
Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
January 1971, Zeitschrift fur Anatomie und Entwicklungsgeschichte,
Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
April 1985, Bulletin of environmental contamination and toxicology,
Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
January 1970, The American journal of physiology,
Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
January 1964, Clinical orthopaedics and related research,
Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
January 1989, Life sciences,
Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
July 1961, Biochemical pharmacology,
Yi-Sen Cheng, and Xiao-Yu Wang, and Guang Wang, and Yan Li, and Yue-Lei Chen, and Man-Li Chuai, and Kenneth Ka Ho Lee, and Xiao-Yan Ding, and Xue-Song Yang
February 2008, Reproductive toxicology (Elmsford, N.Y.),
Copied contents to your clipboard!